Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Investor Meeting to be held on 5th June 2024.30-05-2024
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Investor Meeting to be held on 5th June 2024.Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Investor Meeting to be held on 31st May 2024.Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Investor Meeting to be held on 31st May 2024.Narayana Hrudayalaya Ltd - 539551 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended 31st March 2024.Narayana Hrudayalaya Q4 Results Review - Ebitda Miss Led By India Business: Prabhudas Lilladher
Booked Rs 116 million of loss from its clinics and insurance business.Narayana Hrudayalaya Ltd - 539551 - Audio Recording Of Earnings Call For The Quarter And Financial Year Ended March 31, 2024
Audio Recording of the earnings calls scheduled today i.e. 27th May 2024 for the quarter and financial year ended 31st March 2024.Narayana Hrudayalaya Results Earnings Call for Q4FY24
Conference Call with Narayana Hrudayalaya Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of the audited financial results for the quarter and financial year ended 31st March 2024.Q4FY24 Quarterly & FY24 Annual Result Announced for Narayana Hrudayalaya Ltd.
Healthcare Facilities company Narayana Hrudayalaya announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Consolidated total operating revenue was Rs 12,794 million for Q4 FY24 as compared to Rs 12,216 million in the corresponding period of the previous year, reflecting a growth of +4.7 % YoY and +6.3% QoQ. Consolidated EBITDA* stood at Rs 3,184 million, reflecting a margin of 24.9% as against Rs 2,904 million in Q4 FY23, translating into a growth of +9.7% YoY and +7.3% QoQ. Consolidated PAT* stood at Rs 1,908 million, reflecting a margin of 14.9% as compared to Rs 1,732 million in Q4 FY23, translating into growth of +10.2% YoY and +1.4% QoQ. India operating revenue was Rs 10,352 million for Q4 FY24 as compared to Rs 9,842 million in the corresponding period of the previous year, reflecting a growth of +5.2% YoY and +7.9% QoQ. Cayman operating revenue was Rs 2,528 million for Q4 FY24 as compared to Rs 2,445 million in the corresponding period of the previous year, reflecting a growth of +3.4% YoY and -1.9% QoQ. FY24 Financial Highlights: Consolidated total operating revenue was Rs 50,183 million for FY24 as compared to Rs 45,248 million in FY 23, reflecting a growth of +10.9 %. Consolidated EBITDA stood at Rs 12,275 million for FY24, reflecting a margin of 24.5% as against Rs 10,313 million in FY23, reflecting a growth of +19.0%. Consolidated PAT stood at Rs 7,896 million for FY24, reflecting a margin of 15.7% as compared to Rs 6,066 million in FY23. India operating revenue was Rs 40,365 million for FY24 as compared to Rs 36,774 million in FY23, reflecting a growth of +9.8%. Cayman operating revenue was Rs 10,261 million for FY24 as compared to Rs 8,824 million in FY23, reflecting a growth of +16.3%. Commenting on the performance, Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “The current financial year exhibited strong momentum; we are pleased to report the highest-ever revenue and profitability margins for the financial year, which is on account of improvement in realizations, payor mix and increased patient footfalls during the year. The performance improvement is supported by strong growth in business across our flagship units, other hospitals, and steady improvements in performance of our newer hospitals. HCCI continues to deliver record performance on both revenue and profitability for the current financial year. NHIC has delivered another strong quarter of increased patient transactions. We are confident of delivering on our expectations for the upcoming year. Result PDFNarayana Hrudayalaya Ltd - 539551 - Record Date
The Board in its meeting held on 24th May 2024 has fixed Record date for the dividend subject to the approval of shareholder in the ensuing annual general meeting.